Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.50
Bid: 13.10
Ask: 15.00
Change: 0.50 (3.57%)
Spread: 1.90 (14.504%)
Open: 14.50
High: 14.50
Low: 14.50
Prev. Close: 14.00
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Year Trading Update

10 Oct 2013 07:00

RNS Number : 1559Q
Carclo plc
10 October 2013
 

10 October 2013

 

Carclo plc

("the group")

 

Half year trading update

 

The board is pleased to announce that the group has traded in line with its expectations for the first half of the financial year.

 

Conductive Inkjet Technology's ("CIT's") new Cambridge facility has been commissioned on schedule and production on its high speed coating line was validated on time. Full scale manufacture of coated film to support Atmel Corporation's ("Atmel's") start-up of the XSense™ program has commenced and CIT revenue in the first half of the financial year was approximately £1.4 million. CIT's shipments will support Atmel's previously announced ramp up of XSense™ which will see its adoption in a number of products launched across a range of tier 1 OEMs during the second half of our financial year. CIT has continued to invest in further technology developments that will support future innovation in the touch screen sector. The board remains confident that this business is on track for significant growth this financial year and into the future.

We are pleased to confirm that in its judgement issued on 7th October 2013, the English High Court has determined that CIT may pursue claims against Uni-Pixel Displays Inc ("Uni-Pixel") in the English courts for breach of confidence and patent entitlement. As a result of this successful decision, Uni-Pixel will be obliged to pay the majority of CIT's costs of this jurisdiction application.

At Carclo Diagnostic Solutions the first phase of our external review of market opportunities has indicated good suitability to a wide range of medical device sectors. The second phase of this review is underway and will assist us in identifying detailed target applications and customer opportunities. In parallel, our technical development has been focussed on performance robustness and test repeatability on both the Micropoc-pro and Micropoc-cat platforms with encouraging initial results.

In Technical Plastics profits will, as expected, be ahead of last year's comparative period. Our US business in particular has traded strongly and is set for further growth. Its capacity expansion project is on track for completion early next year. Our US and Czech businesses are both set to benefit in future years from multiple new business wins.

Reported profits in our LED Technologies division are expected to be in line with the prior year first half helped by good growth in our LED Optics business. With design wins already awarded to Wipac, the division is expected to have a much stronger second half due to the phasing of design, development and tooling projects in our Wipac LED supercar lighting business. Further project wins are anticipated for the second half as manufacturers begin to adopt Wipac's new Hyperlite LED modules.

The group's Precision Engineering division has benefitted from a good first half in its aerospace business and reported profits are expected to be comparable to last year's first half performance.

As usual, due to working days and seasonality, the group will generate a larger proportion of its operating profits in the second half of the year and this will be magnified by the projected increase in CIT coated film sales. The commercialisation of CIT and the growth prospects in Technical Plastics and LED Technologies reflect a very positive outlook for the group and the group's financial position remains strong.

The group will issue its interim results for the period to 30 September 2013 on 19 November 2013.

- ENDS -

 

 

Enquiries:

Carclo plc

01924 268040

Chris Malley, Chief Executive

Robert Brooksbank, Finance Director

Weber Shandwick Financial

020 7067 0700

Nick Oborne / Stephanie Badjonat

 

Notes to editors

Carclo plc is a technology led plastics group. It is a public company whose shares are quoted on the London Stock Exchange.

 

Approximately three fifths of sales are derived from the supply of fine tolerance, injection moulded plastic components, which are used in medical, optical and electronics products. This business, Carclo Technical Plastics, operates internationally in a fast growing and dynamic market underpinned by rapid technological development.

 

Approximately two fifths of sales are derived from the supply of specialised precision components to the premium automotive and aerospace industries and LED optics for a wide range of end applications. Carclo is a leader in the development of high power LED lighting for supercars.

 

Carclo's strategy is to develop new technologies and products to drive future growth. Its investment in Conductive Inkjet Technology is at the heart of the newly emerging market for very low cost printed electronics.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLDIRLAIIV
Date   Source Headline
7th Nov 20227:00 amRNSBoard Changes
18th Oct 20227:00 amRNSTrading Update
13th Oct 20221:22 pmRNSHolding(s) in Company
6th Oct 20221:05 pmRNSAppointment of Chief Executive Officer
16th Sep 20223:16 pmRNSHolding(s) in Company
5th Sep 20227:00 amRNSTripartite Financing Agreement Secured
2nd Sep 202212:51 pmRNSHolding(s) in Company - Correction
2nd Sep 202210:37 amRNSHolding(s) in Company
1st Sep 20223:48 pmRNSHolding(s) in Company
1st Sep 20223:20 pmRNSResults of Annual General Meeting
15th Aug 20227:00 amRNSChange of Financial Adviser and Corporate Broker
4th Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 202211:10 amRNS2022 Annual Report and Notice of AGM
18th Jul 20224:41 pmRNSSecond Price Monitoring Extn
18th Jul 20224:35 pmRNSPrice Monitoring Extension
12th Jul 20223:56 pmRNSHolding(s) in Company
30th Jun 20227:20 amRNSNotice of Investor Presentation
30th Jun 20227:00 amRNSFinal Results
28th Jun 20227:00 amRNSNotice of Preliminary Results
7th Jun 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSFull Year Trading Update
9th Mar 20224:41 pmRNSSecond Price Monitoring Extn
9th Mar 20224:36 pmRNSPrice Monitoring Extension
21st Jan 20224:41 pmRNSSecond Price Monitoring Extn
21st Jan 20224:35 pmRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSDirector/PDMR Shareholding
30th Dec 20214:42 pmRNSSecond Price Monitoring Extn
30th Dec 20214:36 pmRNSPrice Monitoring Extension
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20212:57 pmRNSHolding(s) in Company
25th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSHalf Year Results
5th Nov 20217:00 amRNSNotice of Interim Results & Investor Presentation
2nd Sep 20213:08 pmRNSResults of Annual General Meeting
2nd Sep 20217:00 amRNSAGM Trading Update
6th Aug 20217:00 amRNSDirector/PDMR Shareholding
26th Jul 20212:47 pmRNS2021 Annual Report & Notice of AGM
1st Jul 20217:00 amRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSDirector/PDMR Shareholding
30th Jun 20219:29 amRNSNotice of Investor Presentation
30th Jun 20217:00 amRNSPreliminary Results for the year ended 31 March 21
25th Jun 20217:00 amRNSNotice of Preliminary Results
7th May 20214:26 pmRNSHolding(s) in Company
27th Apr 20217:00 amRNSFull Year Trading Update
22nd Apr 20219:13 amRNSHolding(s) in Company
25th Feb 202110:32 amRNSHolding(s) in Company
24th Feb 202110:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.